Given that metformin significantly decreased activation of the TGF-β signaling pathway, and attenuated TGF-β-induced pulmonary fibrosis, we concluded that metformin attenuated EGFR-TKI-induced pulmonary fibrosis by inhibiting the TGF-β signaling pathway. The gene discussed is EGFR; the disease is pulmonary fibrosis.